| Literature DB >> 35351278 |
Felipe F Quezada-Diaz1, J Joshua Smith2.
Abstract
The treatment of locally advanced rectal cancer is challenging and requires a multidisciplinary approach. Neoadjuvant treatment has improved local control by the combination of radiotherapy, surgery, and chemotherapy. However, neoadjuvant treatment has not yet been shown to improve overall survival and is associated with toxicities and late sequelae that impair the quality of life of patients. Currently, different types of neoadjuvant strategies have raised the question about which one is the optimal strategy for rectal cancer treatment. In this article, we explore the different neoadjuvant treatment regimens currently available, their associated benefits and toxicities, and novel approaches in this area.Entities:
Keywords: Chemoradiation; Neoadjuvant therapy; Rectal cancer; Short-course radiotherapy; Total neoadjuvant therapy
Mesh:
Year: 2022 PMID: 35351278 PMCID: PMC9272896 DOI: 10.1016/j.soc.2021.11.008
Source DB: PubMed Journal: Surg Oncol Clin N Am ISSN: 1055-3207 Impact factor: 2.402